Comparison of MAPK and JAK/STAT pathway alterations in EOCRC H/L, LOCRC H/L, and EOCRC NHW patients revealed distinct mutation patterns that may contribute to differences in tumor biology and treatment response. Here, SOAT1 is linked to neoplasm.